{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:33:05Z","timestamp":1790742785206,"version":"4.1.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":882,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shenzhen High-level Hospital Construction Fund","award":["G2022128"],"award-info":[{"award-number":["G2022128"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary arterial hypertension-targeted therapies in portopulmonary hypertension (PoPH) are scarce, let alone for patients with chronic liver failure (CLF) and hepatopulmonary syndrome (HPS). A 48-year male was admitted to the hospital because of cirrhosis for 18 years, systemic oedema, and chest distress after exercise for 1 week. He was diagnosed with CLF, PoPH, and HPS. After 7 weeks of macitentan treatment, the patient's activity tolerance, pulmonary artery systolic pressure, arterial partial pressure of oxygen (PaO2), cTNI, and NT-proBNP changes indicated gradual recovery, without hepatic safety concerns. This case indicated that administering macitentan in patients diagnosed as PoPH (with CLF and HPS) may be efficient and safe enough in a clinical setting.<\/jats:p>","DOI":"10.1002\/ehf2.14431","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T03:50:43Z","timestamp":1686714643000},"page":"2718-2721","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Macitentan Treatment of Portopulmonary Hypertension with Hepatopulmonary Syndrome: A Case Report and Literature Review"],"prefix":"10.1093","volume":"10","author":[{"given":"Niuniu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaolin","family":"Liu","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis , St. Louis ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Shenzhen Third People's Hospital , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2026012114090655700_ehf214431-bib-0001","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012114090655700_ehf214431-bib-0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2021","article-title":"External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry","volume":"59","author":"Boucly","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012114090655700_ehf214431-bib-0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"2026012114090655700_ehf214431-bib-0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J Hepatol"},{"key":"2026012114090655700_ehf214431-bib-0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026012114090655700_ehf214431-bib-0006","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"2026012114090655700_ehf214431-bib-0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012114090655700_ehf214431-bib-0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijcard.2015.11.001","article-title":"Incidence and prevalence of pulmonary arterial hypertension in Germany","volume":"203","author":"Hoeper","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114090655700_ehf214431-bib-0009","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2016.12.014","article-title":"Survival in portopulmonary hypertension: outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry","volume":"36","author":"Sithamparanathan","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026012114090655700_ehf214431-bib-0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology (Baltimore, Md)"},{"key":"2026012114090655700_ehf214431-bib-0011","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/\u22122 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"key":"2026012114090655700_ehf214431-bib-0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012114090655700_ehf214431-bib-0013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"key":"2026012114090655700_ehf214431-bib-0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102071","article-title":"Effects of sildenafil on right ventricle remodelling in portopulmonary hypertension","volume":"70","author":"Rossi","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"2026012114090655700_ehf214431-bib-0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/lt.24198","article-title":"Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transpl"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2718\/64704587\/eschf_10_4_2718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2718\/64704587\/eschf_10_4_2718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:09:41Z","timestamp":1769022581000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/4\/2718\/8285316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14431","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"2022-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}